Pulished Date August, 2019
ID: 3091
Share on
Share on

Middle East And Africa Transfection Reagents And Equipment Market By Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection) And Viral)), Application (Biomedical, Protein Production), End User And Region And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: August, 2019
ID: 3091
Pages: 178

The Middle East and Africa Transfection Reagents and Equipment market size were around USD 33.06 million in 2018. It is expected to grow at a CAGR of 5.6 % to reach USD 43.45 million by 2023. It has the lowest market share of 4%.

The process of inserting genetic material, such as DNA and double-stranded RNA, into mammalian cells is called transfection. Transfection reagents are the substances containing the genetic material whereas the equipment is used as a delivery mechanism.

Many technological advancements happening in the transfection reagents and equipment market over the years has to certain extent addressed the requirements of researchers and biotechnology & biopharmaceutical companies. Transfection instruments with higher efficiency are the result of these advancements. In addition, efficient quantitative and qualitative transfection in a wide variety of cells, including the hard-to-transfect cells are also the result of this.

Technological advancements in transfections, alliances worldwide between the pioneering research institutes to trigger drug discovery, augmented research and development spending along with research activities by pharmaceutical and biotechnology companies, rise in demand for synthetic genes and increasing number of cases of cancer are driving the growth of this market.

Selective effectiveness of transfection reagents, home brew reagents by researchers conjoined with hefty costs of transfection reagents are the primary factors expected to slow down the growth of this market.

The Middle East and Africa Transfection Reagents and Equipment market can be categorized into four categories: by product, by Method, by application and by end user. On the basis of product, Transfection Reagents and Equipment market is classified into Reagents and Instruments. In 2016, the reagents category is projected to account for the biggest market share. Although, the instruments market is probably grow at the highest CAGR during the aforementioned forecast period. If we go by Method, Transfection Reagents and Equipment market is segmented into Biochemical, Calcium Phosphate, Lipofection, DEAE-dextran, Dendrimers, Physical, Electroporation, Nucleofection, Others and Viral. In 2016, the biochemical category is projected to command the largest market share, whereas the viral category is estimated to grow at the highest CAGR during the aforementioned forecast period. Further, on the basis of application the market can be categorized into Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production and Therapeutic Delivery. In 2016, the biomedical research category is likely to command the largest market share. Last but not the least, on the basis of end user the market is segmented into Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. In 2016, the academic & research institutes category is likely to command the largest market share. Although, the pharmaceutical & biotechnologies category is estimated to grow at the highest CAGR during the aforementioned forecast period.

By geography, the Middle East and Africa Transfection Reagents and Equipment market has been categorized into Middle East and Africa. It is the last in terms of market share.

Major companies in the Transfection Reagents and Equipment market are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). These companies hold a leading position in the transfection reagent and equipment market because of their well-established presence in the fields of genomics, spanning fifty countries, heavy R&D investments, and strong sales as well as distribution force. Other players in the market include Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                                        

                                5.1.1 Reagents                                 

                                5.1.2 Instruments                                           

                                5.1.3  Y-o-Y Growth Analysis, By Product                                              

                                5.1.4  Market Attractiveness Analysis, By Product                                            

                                5.1.5  Market Share Analysis, By Product                                              

                5.2 Method                                                      

                                5.2.1 Biochemical                                            

                                5.2.2 Calcium Phosphate                                              

                                                5.2.2.1 Lipofection                          

                                                                5.2.2.1.1 Advantages     

                                                                5.2.2.1.2 Disadvantages

                                                5.2.2.2 Calcium Phosphate                          

                                                                5.2.2.2.1 Advantages     

                                                                5.2.2.2.2 Disadvantages

                                                5.2.2.3 DEAE-dextran                    

                                                                5.2.2.3.1 Advantages     

                                                                5.2.2.3.2 Disadvantages

                                                5.2.2.4 Dendrimers                         

                                                                5.2.2.4.1 Advantages     

                                                                5.2.2.5.1 Disadvantages

                                5.2.3 Physical                                    

                                                5.2.3.1 Electroporation                 

                                                                5.2.3.1.1 Advantages     

                                                                5.2.3.1.2 Disadvantages

                                                5.2.3.2 Nucleofection                    

                                                                5.2.3.2.1 Advantages     

                                                                5.2.3.2.2 Disadvantages

                                                5.2.3.3.Others                  

                                                                5.2.3.3.1 Sonoporation 

                                                                5.2.3.3.2 Genegun          

                                                                                5.2.3.3.2.1 Advantages

                                                                                5.2.3.3.2.2 Disadvantages

                                                                5.2.3.3.3 Magnetofection            

                                                                                5.2.3.3.3.1 Advantages

                                                                                5.2.3.3.3.2 Disadvantages

                                                                5.2.3.3.4 Optoinjection 

                                                                                5.2.3.3.4.1 Advantages

                                                                                5.2.3.3.4.2 Disadvantages

                                5.2.4 Viral                                           

                                                5.2.4.1 Adenoviruses                     

                                                5.2.4.2 Retroviruses                       

                                                5.2.4.3 Adenoassociated Viruses (AAV)                

                                5.2.5 Y-o-Y Growth Analysis, By Method                                            

                                5.2.6 Market Attractiveness Analysis, By Method                                         

                                5.2.7 Market Share Analysis, By Method                                            

                5.3 Application                                                 

                                5.3.1 Biomedical Research                                           

                                                5.3.1.1 Gene Expression Studies                              

                                                5.3.1.2 Cancer Research                               

                                                5.3.1.3 Transgenic Model                             

                                5.3.2 Protein Production                                              

                                5.3.3 Therapeutic Delivery                                          

                                5.3.4 Y-o-Y Growth Analysis, By Application                                         

                                5.3.5  Market Attractiveness Analysis, By Application                                      

                                5.3.6  Market Share Analysis, By Application                                       

                5.4 End User                                                      

                                5.4.1 Academic & Research Institutes                                    

                                5.4.2 Pharmaceutical & Biotechnology Companies                                           

                                5.4.3 Y-o-Y Growth Analysis, By End User                                             

                                5.4.4  Market Attractiveness Analysis, By End User                                          

                                5.4.5  Market Share Analysis, By End User                                            

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Method                        

                                                6.1.3.4 By Application                    

                                                6.1.3.5 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Method                         

                                                6.1.4.4 By Application                    

                                                6.1.4.5 By End User                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Method                        

                                                6.1.5.4 By Application                    

                                                6.1.5.5 By End User                        

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Thermo Fisher Scientific Inc. (U.S.)                                                   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Promega Corporation (U.S.)                                                

                8.3 Hoffmann-La Roche Ltd. (Switzerland)                                                           

                8.4 QIAGEN N.V. (Netherlands)                                                

                8.5 Polyplus-transfection SA (France)                                                    

                8.6 Bio-Rad Laboratories (U.S.)                                                 

                8.7 Lonza Group (Switzerland)                                                  

                8.8 Sigma-Aldrich Corporation (U.S.)                                                      

                8.9 Mirus Bio LLC (U.S.)                                                 

                8.10 MaxCyte Inc. (U.S.)                                                              

9.Competitive Landscape                                                                            

                9.1 Market share analysis     &

  • Regional-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Method, Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Transfection Reagents and Equipment Market By Product, From 2018-2023 ( USD Million )
  2. Middle East & Africa Reagents Market By Region, From 2018-2023 ( USD Million )
  3. Middle East & Africa Instruments Market By Region, From 2018-2023 ( USD Million )
  4. Middle East & Africa Transfection Reagents and Equipment Market By Method, From 2018-2023 ( USD Million )
  5. Middle East & Africa Biochemical Market By Region, From 2018-2023 ( USD Million )
  6. Middle East & Africa Calcium Phosphate Market By Region, From 2018-2023 ( USD Million )
  7. Middle East & Africa Lipofection Market By Region, From 2018-2023 ( USD Million )
  8. Middle East & Africa DEAE-dextran Market By Region, From 2018-2023 ( USD Million )
  9. Middle East & Africa Dendrimers Market By Region, From 2018-2023 ( USD Million )
  10. Middle East & Africa Physical Market By Region, From 2018-2023 ( USD Million )
  11. Middle East & Africa Electroporation Market By Region, From 2018-2023 ( USD Million )
  12. Middle East & Africa Nucleofection Market By Region, From 2018-2023 ( USD Million )
  13. Middle East & Africa Others Market By Region, From 2018-2023 ( USD Million )
  14. Middle East & Africa Viral Market By Region, From 2018-2023 ( USD Million )
  15. Middle East & Africa Transfection Reagents and Equipment Market By Application, From 2018-2023 ( USD Million )
  16. Middle East & Africa Biomedical Research Market By Region, From 2018-2023 ( USD Million )
  17. Middle East & Africa Gene Expression Studies Market By Region, From 2018-2023 ( USD Million )
  18. Middle East & Africa Cancer Research Market By Region, From 2018-2023 ( USD Million )
  19. Middle East & Africa Transgenic Model Market By Region, From 2018-2023 ( USD Million )
  20. Middle East & Africa Protein Production Market By Region, From 2018-2023 ( USD Million )
  21. Middle East & Africa Therapeutic Delivery Market By Region, From 2018-2023 ( USD Million )
  22. Middle East & Africa Transfection Reagents and Equipment Market By End User, From 2018-2023 ( USD Million )
  23. Middle East & Africa Academic & Research Institutes Market By Region, From 2018-2023 ( USD Million )
  24. Middle East & Africa Pharmaceutical & Biotechnology Companies Market By Region, From 2018-2023 ( USD Million )
  25. Middle East Transfection Reagents and Equipment Market By Product, From 2018-2023 ( USD Million )
  26. Middle East Transfection Reagents and Equipment Market By Method, From 2018-2023 ( USD Million )
  27. Middle East Transfection Reagents and Equipment Market By Application, From 2018-2023 ( USD Million )
  28. Middle East Transfection Reagents and Equipment Market By End User, From 2018-2023 ( USD Million )
  29. Africa Transfection Reagents and Equipment Market By Product, From 2018-2023 ( USD Million )
  30. Africa Transfection Reagents and Equipment Market By Method, From 2018-2023 ( USD Million )
  31. Africa Transfection Reagents and Equipment Market By Application, From 2018-2023 ( USD Million )
  32. Africa Transfection Reagents and Equipment Market By End User, From 2018-2023 ( USD Million )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample